Literature DB >> 36191230

CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model.

Jiaxi Yu1,2, Tongling Liufu1,2, Yilei Zheng3, Jin Xu4, Lingchao Meng1,2, Wei Zhang1,2, Yun Yuan1,2, Daojun Hong3,5, Nicolas Charlet-Berguerand6, Zhaoxia Wang1,2, Jianwen Deng1,2.   

Abstract

Neuronal intranuclear inclusion disease (NIID) is a neuromuscular/neurodegenerative disease caused by the expansion of CGG repeats in the 5' untranslated region (UTR) of the NOTCH2NLC gene. These repeats can be translated into a polyglycine-containing protein, uN2CpolyG, which forms protein inclusions and is toxic in cell models, albeit through an unknown mechanism. Here, we established a transgenic Drosophila model expressing uN2CpolyG in multiple systems, which resulted in progressive neuronal cell loss, locomotor deficiency, and shortened lifespan. Interestingly, electron microscopy revealed mitochondrial swelling both in transgenic flies and in muscle biopsies of individuals with NIID. Immunofluorescence and immunoelectron microscopy showed colocalization of uN2CpolyG with mitochondria in cell and patient samples, while biochemical analysis revealed that uN2CpolyG interacted with a mitochondrial RNA binding protein, LRPPRC (leucine-rich pentatricopeptide repeat motif-containing protein). Furthermore, RNA sequencing (RNA-seq) analysis and functional assays showed down-regulated mitochondrial oxidative phosphorylation in uN2CpolyG-expressing flies and NIID muscle biopsies. Finally, idebenone treatment restored mitochondrial function and alleviated neurodegenerative phenotypes in transgenic flies. Overall, these results indicate that transgenic flies expressing uN2CpolyG recapitulate key features of NIID and that reversing mitochondrial dysfunction might provide a potential therapeutic approach for this disorder.

Entities:  

Keywords:  idebenone treatment; mitochondrial oxidative phosphorylation defects; neuronal intranuclear inclusion disease; polyG; transgenic Drosophila model

Mesh:

Substances:

Year:  2022        PMID: 36191230      PMCID: PMC9565157          DOI: 10.1073/pnas.2208649119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  68 in total

1.  FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor/ataxia syndrome [FXTAS].

Authors:  Dhruv Gohel; Lakshmi Sripada; Paresh Prajapati; Kritarth Singh; Milton Roy; Darshan Kotadia; Flora Tassone; Nicolas Charlet-Berguerand; Rajesh Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-13       Impact factor: 5.187

2.  Expansion of GGC repeat in the human-specific NOTCH2NLC gene is associated with essential tremor.

Authors:  Qi-Ying Sun; Qian Xu; Yun Tian; Zheng-Mao Hu; Li-Xia Qin; Jin-Xia Yang; Wen Huang; Jin Xue; Jin-Chen Li; Sheng Zeng; Ying Wang; Hao-Xuan Min; Xiao-Yu Chen; Jun-Pu Wang; Bin Xie; Fan Liang; Hai-Nan Zhang; Chun-Yu Wang; Li-Fang Lei; Xin-Xiang Yan; Hong-Wei Xu; Ran-Hui Duan; Kun Xia; Jing-Yu Liu; Hong Jiang; Lu Shen; Ji-Feng Guo; Bei-Sha Tang
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 3.  New developments in pharmacotherapy for Friedreich ataxia.

Authors:  Alexandra Clay; Patrick Hearle; Kim Schadt; David R Lynch
Journal:  Expert Opin Pharmacother       Date:  2019-07-16       Impact factor: 3.889

Review 4.  NOTCH2NLC-related disorders: the widening spectrum and genotype-phenotype correlation.

Authors:  Yu Fan; Yuming Xu; Changhe Shi
Journal:  J Med Genet       Date:  2021-10-21       Impact factor: 6.318

5.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.

Authors:  Y Trottier; Y Lutz; G Stevanin; G Imbert; D Devys; G Cancel; F Saudou; C Weber; G David; L Tora
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

6.  Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.

Authors:  Renate K Hukema; Ronald A M Buijsen; Chris Raske; Lies Anne Severijnen; Ingeborg Nieuwenhuizen-Bakker; Michelle Minneboo; Alex Maas; Rini de Crom; Johan M Kros; Paul J Hagerman; Robert F Berman; Rob Willemsen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders.

Authors:  Lanxiao Cao; Yaping Yan; Guohua Zhao
Journal:  Neurol Sci       Date:  2021-08-01       Impact factor: 3.307

Review 8.  Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.

Authors:  J C Gillis; P Benefield; D McTavish
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

9.  Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease.

Authors:  Jianwen Deng; Binbin Zhou; Jiaxi Yu; Xiaochen Han; Jianhui Fu; Xiaobin Li; Xufang Xie; Min Zhu; Yilei Zheng; Xueyu Guo; Pidong Li; Qingqing Wang; Jing Liu; Wei Zhang; Yun Yuan; Sheng Yao; Zhaoxia Wang; Daojun Hong
Journal:  J Med Genet       Date:  2021-03-25       Impact factor: 6.318

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.